• Home
  • Latest
  • Politics
  • Metro
  • Markets
  • Sports
  • About us
×
LATEST
2021-08-05 Foxconn targets EV chip market with purchase of $90.8 million wafer plant from Macronix 2021-08-05 Nintendo quarterly sales slump for its flagship Switch console 2021-08-05 Biden sets target for 50% EVs by 2030 2021-08-05 ByteDance to lay off staff and close businesses over China tutoring clampdown 2021-08-05 Uber posts $509 million loss on driver incentives 2021-08-05 India threatens Flipkart with $1.35 billion fine 2021-08-05 Bayer buys biopharma firm Vividion Therapeutics for up to $2 billion 2021-08-05 Adidas hikes outlook despite hit to China sales 2021-08-05 Siemens beats quarter forecasts, raises profit guidance for third time 2021-08-04 Interpol declares Gloria Osei, husband, Muyiwa Folorunsho, wanted for alleged investment fraud
 Posted in Big Business, Latest

Brief: Merck is buying drug maker VelosBio for $2.75 billion in cash

 November 5, 2020

Merck (MRK) – Merck is buying privately held drugmaker VelosBio for $2.75 billion in cash, in a move designed to boost its oncology treatment pipeline.

Sharing is caring!

  • Facebook
  • LinkedIn
  • Twitter
  • Telegram
  • WhatsApp
  • Skype

Related

Share:
Tagged Merk

Related Articles

  • Sakiru Oyefeso
    Great Nigeria insurance posts 21% fall in profit for q2
  • Nigerian unit of Vodacom Business Africa appoints Valentine Chime as Managing Director
  • U.S. federal contract ban takes effect for companies using products from Huawei, others
  • baidu
    Baidu to launch paid driverless ride-hailing services in Beijing

Post navigation

← Novavax and Australia agree on acquisition of Novavax COVID-19
GM profit beat driven by strength in trucks, SUVs and China rebound →

Copyrights © 2016-2020. PageOne.ng, All Rights Reserved

Design by ThemesDNA.com